Journal article
A Druglike Ferrostatin‐1 Analogue as a Ferroptosis Inhibitor and Photoluminescent Indicator
Abstract
Abstract Redox‐based diagnostic and therapeutic applications have long suffered from a shortage of suitable drugs and probes of high specificity. In the context of anti‐ferroptosis research for neurological diseases, the inaccessibility of a blood–brain barrier (BBB) permeable small molecular ferroptosis inhibitor, and the lack of specific ferroptosis probes, seriously impeded a deeper understanding of the mechanism of ferroptosis and the …
Authors
Yan J; Bao L; Liang H; Zhao L; Liu M; Kong L; Fan X; Liang C; Liu T; Han X
Journal
Angewandte Chemie, Vol. 137, No. 20,
Publisher
Wiley
Publication Date
May 12, 2025
DOI
10.1002/ange.202502195
ISSN
0044-8249